XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income $ 89,382 $ 58,816
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 16,465 12,876
Gain on sale of operations, net (135) (6,385)
Bad debt expense, net of recoveries 1,263 265
Adjustment to contingent earnout liability 1,478 753
Stock-based compensation expense 6,428 5,454
Deferred income taxes 4,688 5,360
Other, net 211 (478)
Changes in assets and liabilities, net of acquisitions and divestitures:    
Accounts receivable, net (138,658) (69,363)
Other assets (1,696) (11,279)
Accounts payable 57,837 36,574
Income taxes payable 11,252 (769)
Accrued personnel costs (11,176) (7,634)
Other liabilities (8,822) 42,117
Operating cash flows provided by continuing operations 28,517 66,307
Operating cash flows used in discontinued operations (9) (13)
Net cash provided by operating activities 28,508 66,294
Cash flows from investing activities:    
Business acquisitions and purchases of client lists, net of cash acquired (72,469) (43,172)
Purchases of client fund investments (18,271) (7,900)
Proceeds from the sales and maturities of client fund investments 8,505 7,965
Proceeds from sales of divested operations 190 9,785
Change in funds held for clients (2,468) (4,029)
Additions to property and equipment (3,640) (3,258)
Other, net (1,603) 472
Net cash used in investing activities (89,756) (40,137)
Cash flows from financing activities:    
Proceeds from bank debt 447,300 431,700
Payment of bank debt (336,600) (376,400)
Payment for acquisition of treasury stock (34,354) (64,506)
Indirect repurchase of shares for minimum tax withholding (7,289) (3,037)
Changes in client funds obligations 29,014 (27,823)
Proceeds from exercise of stock options 3,896 5,448
Payment of contingent consideration for acquisitions (8,240) (7,850)
Other, net (2,072) (114)
Net cash provided by (used in) financing activities 91,655 (42,582)
Net increase (decrease) in cash, cash equivalents and restricted cash 30,407 (16,425)
Cash, cash equivalents and restricted cash at beginning of year 150,474 170,335
Cash, cash equivalents and restricted cash at end of period 180,881 153,910
Reconciliation of cash, cash equivalents and restricted cash to the   Condensed Consolidated Balance Sheets:    
Cash and cash equivalents 3,881 4,677
Restricted cash 42,188 39,268
Cash equivalents included in funds held for clients 134,812 109,965
Total cash, cash equivalents and restricted cash $ 180,881 $ 153,910